Malaria
Abstract
Malaria has had a greater impact on world history than any other infectious disease. More than 300 to 500 million individuals worldwide are infected with Plasmodium spp, and 1.5 to 2.7 million people a year, most of whom are children, die from the infection. Malaria is endemic in over 90 countries in which 2400 million people live; this represents 40% of the world’s population. Approximately 90% of malaria deaths occur in Africa. Despite continuing efforts in vaccine development, malaria prevention is difficult, and no drug is universally effective. This article examines malaria caused by the 4 most common Plasmodium spp that infect humans, P vivax, P ovale, P malariae, and P falciparum, as well as mixed infections and the simian parasite P knowlesi. A comprehensive review of the microbiology, clinical presentation, pathogenesis, diagnosis, and treatment of these forms of malaria is given.
2010 Elsevier Inc. All rights reserved.
Similar articles
- [Tropical malaria–danger for persons visiting endemic areas].Zdrodowska A, Zajkowska J, Golian J, Grygorczuk S, Krupa W, Kondrusik M.Przegl Lek. 2006;63(3):162-5.PMID: 16969901 Polish.
- Conquering the intolerable burden of malaria: what’s new, what’s needed: a summary.Breman JG, Alilio MS, Mills A.Am J Trop Med Hyg. 2004 Aug;71(2 Suppl):1-15.PMID: 15331814 Review.
- Imported non-Plasmodium falciparum malaria: a five-year prospective study in a European referral center.Bottieau E, Clerinx J, Van Den Enden E, Van Esbroeck M, Colebunders R, Van Gompel A, Van Den Ende J.Am J Trop Med Hyg. 2006 Jul;75(1):133-8.PMID: 16837719
- Development of malaria vaccines that block transmission of parasites by mosquito vectors.Hisaeda H, Yasutomo K.J Med Invest. 2002 Aug;49(3-4):118-23.PMID: 12323000 Review.
- Malaria vaccines.Gordon DM.Infect Dis Clin North Am. 1990 Jun;4(2):299-313.PMID: 2189001 Review.
Cited by
- Diagnostic accuracy of the point-of-care standard G6PD test™ (SD Biosensor) for glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis.Martínez JC, Vélez-Marín V, Lopez-Perez M, Patiño-Lugo DF, Florez ID.Malar J. 2024 Nov 2;23(1):327. doi: 10.1186/s12936-024-05144-1.PMID: 39488711 Free PMC article.
- Profile and Determinants for Complications of Imported Malaria in 5 Chinese Provinces From 2014 to 2021: Retrospective Analysis.Liu B, Zhang T, Wang D, Xia S, Li W, Zhang X, Wang S, Guo XK, Zhou XN, Li S.JMIR Public Health Surveill. 2024 Aug 30;10:e52089. doi: 10.2196/52089.PMID: 39212596 Free PMC article.
- First-in-human, randomized, double-blind, placebo-controlled, single and multiple ascending doses clinical study to assess the safety, tolerability, and pharmacokinetics of cipargamin administered intravenously in healthy adults.Venishetty VK, Lecot J, Nguyen A, Zhang J, Prince WT.Antimicrob Agents Chemother. 2024 Sep 4;68(9):e0128723. doi: 10.1128/aac.01287-23. Epub 2024 Jul 26.PMID: 39058022 Free PMC article. Clinical Trial.
- Landscape and Socioeconomic Factors Determine Malaria Incidence in Tropical Forest Countries.Bailey A, Prist PR.Int J Environ Res Public Health. 2024 Apr 30;21(5):576. doi: 10.3390/ijerph21050576.PMID: 38791790 Free PMC article.
- Patient with suspected co-infection of hemorrhagic fever with renal syndrome and malaria: a case report.Zhao HD, Qian HB, Wang ZK, Ren RK, Yu TB, Liu HL.Front Med (Lausanne). 2024 May 1;11:1341015. doi: 10.3389/fmed.2024.1341015. eCollection 2024.PMID: 38751985 Free PMC article.